Dianthus Therapeutics Inc. – Underwriting Agreements

NASDAQ: DNTH
Share price (6/2/26): $81.57
Market cap (6/2/26): $4.459 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 49 pages 7,313,582 Shares and Pre-Funded Warrants to Purchase 402,468 Shares Dianthus Therapeutics, Inc. Underwriting Agreement

from 8-K 47 pages 6,487,879 Shares and Pre-Funded Warrants to Purchase 1,112,121 Shares Dianthus Therapeutics, Inc. Underwriting Agreement

from S-3 42 pages Dianthus Therapeutics, Inc. $200,000,000 Common Stock Sales Agreement

from S-3 4 pages Amendment No. 1 to Sales Agreement

from S-3 36 pages Magenta Therapeutics, Inc. $100,000,000 Common Stock Sales Agreement

from 8-K 43 pages Magenta Therapeutics, Inc. 7,500,000 Shares of Common Stock Underwriting Agreement

from 8-K 43 pages Magenta Therapeutics, Inc. 7,500,000 Shares of Common Stock Underwriting Agreement

from S-3 36 pages Magenta Therapeutics, Inc. $100,000,000 Common Stock Sales Agreement

from S-1 42 pages Magenta Therapeutics, Inc. [ • ] Shares of Common Stock Underwriting Agreement

from S-1 47 pages Magenta Therapeutics, Inc. [•] Shares of Common Stock Underwriting Agreement